Viral appropriation of apoptotic and NF‐κB signaling pathways
暂无分享,去创建一个
[1] Daniel R. Caffrey,et al. LPS-TLR4 Signaling to IRF-3/7 and NF-κB Involves the Toll Adapters TRAM and TRIF , 2003, The Journal of experimental medicine.
[2] S. Howell,et al. KSHV vFLIP binds to IKK-γ to activate IKK , 2003, Journal of Cell Science.
[3] S. Ross,et al. Viruses and Toll-like receptors. , 2003, Microbes and infection.
[4] Jiahuai Han,et al. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling , 2003, Nature.
[5] R. Sun,et al. NF-κB Inhibits Gammaherpesvirus Lytic Replication , 2003, Journal of Virology.
[6] G. McFadden,et al. Poxvirus Immunomodulatory Strategies: Current Perspectives , 2003, Journal of Virology.
[7] C. Fielding,et al. Latent Membrane Protein 1 Inhibits Epstein-Barr Virus Lytic Cycle Induction and Progress via Different Mechanisms , 2003, Journal of Virology.
[8] I. Haga,et al. The Poxvirus Protein A52R Targets Toll-like Receptor Signaling Complexes to Suppress Host Defense , 2003, The Journal of experimental medicine.
[9] Sophie Janssens,et al. Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members. , 2003, Molecular cell.
[10] T. Akazawa,et al. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3–mediated interferon-β induction , 2003, Nature Immunology.
[11] I. Mohr,et al. Identification of a Lytic-Cycle Epstein-Barr Virus Gene Product That Can Regulate PKR Activation , 2003, Journal of Virology.
[12] S. Akira,et al. Cutting Edge: A Novel Toll/IL-1 Receptor Domain-Containing Adapter That Preferentially Activates the IFN-β Promoter in the Toll-Like Receptor Signaling1 , 2002, The Journal of Immunology.
[13] G. McFadden,et al. The Myxoma Poxvirus Protein, M11L, Prevents Apoptosis by Direct Interaction with the Mitochondrial Permeability Transition Pore , 2002, The Journal of experimental medicine.
[14] L. Kirshenbaum,et al. IKKβ Is Required for Bcl-2-mediated NF-κB Activation in Ventricular Myocytes* , 2002, The Journal of Biological Chemistry.
[15] D. Green,et al. The Lymphotoxin-β Receptor Induces Different Patterns of Gene Expression via Two NF-κB Pathways , 2002 .
[16] M. Stanley,et al. Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential , 2002, Clinical and experimental dermatology.
[17] J. Langland,et al. The role of the PKR-inhibitory genes, E3L and K3L, in determining vaccinia virus host range. , 2002, Virology.
[18] T. Hofmann,et al. The Human Papillomavirus Oncoprotein E7 Attenuates NF-κB Activation by Targeting the IκB Kinase Complex* , 2002, The Journal of Biological Chemistry.
[19] J. Panus,et al. Cowpox virus encodes a fifth member of the tumor necrosis factor receptor family: A soluble, secreted CD30 homologue , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[20] B. Williams,et al. Blockade of Interferon Induction and Action by the E3L Double-Stranded RNA Binding Proteins of Vaccinia Virus , 2002, Journal of Virology.
[21] D. Bellows,et al. Epstein-Barr Virus BALF1 Is a BCL-2-Like Antagonist of the Herpesvirus Antiapoptotic BCL-2 Proteins , 2002, Journal of Virology.
[22] Geoffrey L. Smith,et al. Vaccinia virus CrmE encodes a soluble and cell surface tumor necrosis factor receptor that contributes to virus virulence. , 2002, Virology.
[23] F. Osorio,et al. The Genome of Swinepox Virus , 2002, Journal of Virology.
[24] M. Esteban,et al. MC159L protein from the poxvirus molluscum contagiosum virus inhibits NF-kappaB activation and apoptosis induced by PKR. , 2001, The Journal of general virology.
[25] R. Flavell,et al. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 , 2001, Nature.
[26] C. Benedict,et al. Virus targeting of the tumor necrosis factor superfamily. , 2001, Virology.
[27] D. Pickup,et al. Cowpox virus and other members of the orthopoxvirus genus interfere with the regulation of NF-kappaB activation. , 2001, Virology.
[28] S. Swain,et al. Interleukin 18 , 2001, The Journal of experimental medicine.
[29] A. Alcamí,et al. The Vaccinia Virus Soluble Alpha/Beta Interferon (IFN) Receptor Binds to the Cell Surface and Protects Cells from the Antiviral Effects of IFN , 2000, Journal of Virology.
[30] T. Wirth,et al. NF-κB transcription factors: critical regulators of hematopoiesis and neuronal survival , 2000 .
[31] D. Greaves,et al. Mechanism of inactivation of NF-kappa B by a viral homologue of I kappa b alpha. Signal-induced release of i kappa b alpha results in binding of the viral homologue to NF-kappa B. , 2000, The Journal of biological chemistry.
[32] E. Harhaj,et al. Domain-specific Interaction with the IκB Kinase (IKK) Regulatory Subunit IKKγ Is an Essential Step in Tax-mediated Activation of IKK* , 2000, The Journal of Biological Chemistry.
[33] J. Sample,et al. Epstein-Barr Virus Small RNAs Potentiate Tumorigenicity of Burkitt Lymphoma Cells Independently of an Effect on Apoptosis , 2000, Journal of Virology.
[34] S. Akira,et al. The role of Toll-like receptors and MyD88 in innate immune responses , 2000, Journal of endotoxin research.
[35] E. Cesarman,et al. Inhibition of NF-kappaB induces apoptosis of KSHV-infected primary effusion lymphoma cells. , 2000, Blood.
[36] A. Bowie,et al. A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[37] Y. Lazebnik,et al. Antiapoptotic Herpesvirus Bcl-2 Homologs Escape Caspase-Mediated Conversion to Proapoptotic Proteins , 2000, Journal of Virology.
[38] M. Horwitz,et al. Regulation of the NF-κB Activation Pathway by Isolated Domains of FIP3/IKKγ, a Component of the IκB-α Kinase Complex* , 2000, The Journal of Biological Chemistry.
[39] S. Maruo,et al. Oncogenic Role of Epstein-Barr Virus-Encoded RNAs in Burkitt’s Lymphoma Cell Line Akata , 1999, Journal of Virology.
[40] R. Flavell,et al. Lymphotoxin-β-deficient mice show defective antiviral immunity , 1999 .
[41] T. Graf,et al. Epstein-Barr Virus Encodes a Novel Homolog of the bcl-2 Oncogene That Inhibits Apoptosis and Associates with Bax and Bak , 1999, Journal of Virology.
[42] J. Sample,et al. Epstein-Barr Virus Regulates c-MYC, Apoptosis, and Tumorigenicity in Burkitt Lymphoma , 1999, Molecular and Cellular Biology.
[43] D. Faller,et al. Arginine butyrate-induced susceptibility to ganciclovir in an Epstein-Barr-virus-associated lymphoma. , 1998, Blood cells, molecules & diseases.
[44] Rouse Bt,et al. A skeptical look at viral immune evasion. , 1997 .
[45] A Ciechanover,et al. Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[46] M. Jäättelä,et al. The ability of BHRF1 to inhibit apoptosis is dependent on stimulus and cell type , 1997, Journal of virology.
[47] G M Cohen,et al. Caspases: the executioners of apoptosis. , 1997, The Biochemical journal.
[48] J. Tschopp,et al. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors , 1997, Nature.
[49] J. Russo,et al. Kaposi's sarcoma-associated herpesvirus encodes a functional Bcl-2 homologue , 1997, Nature Medicine.
[50] A. Alcamí,et al. A mechanism for the inhibition of fever by a virus. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[51] S. Der,et al. Involvement of the double-stranded-RNA-dependent kinase PKR in interferon expression and interferon-mediated antiviral activity. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[52] C. Ware,et al. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family , 1995, Cell.
[53] P. Hershberger,et al. The apoptotic suppressor P35 is required early during baculovirus replication and is targeted to the cytosol of infected cells , 1994, Journal of virology.
[54] Z. Oltvai,et al. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax , 1994, Nature.
[55] M. Rowe,et al. Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[56] R. Black,et al. Viral inhibition of inflammation: Cowpox virus encodes an inhibitor of the interleukin-1β converting enzyme , 1992, Cell.
[57] C. Dinarello. Interleukin-1 and interleukin-1 antagonism. , 1991, Blood.
[58] L. Heston,et al. Transfection of a rearranged viral DNA fragment, WZhet, stably converts latent Epstein-Barr viral infection to productive infection in lymphoid cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[59] R. Sun,et al. NF-kappaB inhibits gammaherpesvirus lytic replication. , 2003, Journal of virology.
[60] S. Howell,et al. KSHV vFLIP binds to IKK-gamma to activate IKK. , 2003, Journal of cell science.
[61] L. Kirshenbaum,et al. IKK beta is required for Bcl-2-mediated NF-kappa B activation in ventricular myocytes. , 2002, The Journal of biological chemistry.
[62] D. Green,et al. The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways. , 2002, Immunity.
[63] T. Hofmann,et al. The human papillomavirus oncoprotein E7 attenuates NF-kappa B activation by targeting the Ikappa B kinase complex. , 2002, The Journal of biological chemistry.
[64] J. Ye,et al. Regulation of the NF-kappaB activation pathway by isolated domains of FIP3/IKKgamma, a component of the IkappaB-alpha kinase complex. , 2000, The Journal of biological chemistry.
[65] M. Karin,et al. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. , 2000, Annual review of immunology.
[66] S P Lawrence,et al. Advances in the treatment of hepatitis C. , 2000, Advances in internal medicine.
[67] E. Harhaj,et al. Domain-specific interaction with the I kappa B kinase (IKK)regulatory subunit IKK gamma is an essential step in tax-mediated activation of IKK. , 2000, The Journal of biological chemistry.
[68] R. Flavell,et al. Lymphotoxin-beta-deficient mice show defective antiviral immunity. , 1999, Virology.
[69] H. Heslop,et al. Control of virus-induced lymphoproliferation: Epstein-Barr virus-induced lymphoproliferation and host immunity. , 1997, Molecular medicine today.
[70] T. Chatila,et al. Cyclosporin A‐sensitive induction of the Epstein‐Barr virus lytic switch is mediated via a novel pathway involving a MEF2 family member , 1997, The EMBO journal.
[71] P. Latreille,et al. Copyright © 1997, American Society for Microbiology Complete Sequence and Genomic Analysis of Murine , 1997 .
[72] E. Kieff. Epstein-Barr virus and its replication , 1996 .